Multiplex Testing: CDRH Guidance Provokes Array Of Industry Comments
This article was originally published in The Gray Sheet
Executive Summary
Abbott Labs is urging CDRH to clarify that its April 1draft guidance on multiplex tests for heritable markers, mutations and expression patterns applies only to device submissions